These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24182973)

  • 1. Office-based management of impotence and Peyronie's disease.
    Tapscott AH; Hakim LS
    Urol Clin North Am; 2013 Nov; 40(4):521-43. PubMed ID: 24182973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction.
    Kadioglu A; Oktar T; Kandirali E; Kendirci M; Sanli O; Ozsoy C
    Int J Impot Res; 2004 Dec; 16(6):540-3. PubMed ID: 15116064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peyronie's disease in diabetic patients being screened for erectile dysfunction.
    El-Sakka AI; Tayeb KA
    J Urol; 2005 Sep; 174(3):1026-30. PubMed ID: 16094040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease].
    Zhu JY; Jiang R
    Zhonghua Nan Ke Xue; 2014 Sep; 20(9):846-9. PubMed ID: 25306816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
    Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
    Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate.
    Levine LA; Latchamsetty KC
    Int J Impot Res; 2002 Dec; 14(6):478-82. PubMed ID: 12494281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction.
    Jarow JP; Lowe FC
    J Urol; 1997 Oct; 158(4):1388-90. PubMed ID: 9302127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the course of Peyronie's disease.
    Garaffa G; Trost LW; Serefoglu EC; Ralph D; Hellstrom WJ
    Int J Clin Pract; 2013 Aug; 67(8):781-8. PubMed ID: 23869679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technological Advancements for Treating Erectile Dysfunction and Peyronie's Disease.
    Campbell JD; Matti D; Abed H; Di Pierdominico A
    Urol Clin North Am; 2022 Feb; 49(1):175-184. PubMed ID: 34776050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biotherapies for erectile dysfunction and Peyronie's disease: Where are we now?].
    Akakpo W; Schirmann A; Ferretti L; Ben-Naoum K; Carnicelli D; Graziana JP; Hupertan V; Madec FX; Marcelli F; Methorst C; Morel-Journel N; Savareux L; Terrier JE; Faix A; Huyghe E; Yiou R
    Prog Urol; 2020 Dec; 30(16):1000-1013. PubMed ID: 32826194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile dysfunction and Peyronie's disease diagnosis rates after penile fracture-a retrospective claims database cohort analysis.
    Maremanda AP; Du Comb W; Able C; Kohn TP; Unal S; Burnett AL
    Int J Impot Res; 2024 Apr; 36(2):125-128. PubMed ID: 37542153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie's disease or erectile dysfunction and does not correlate with Peyronie's disease severity.
    Kirby EW; Verges D; Matthews J; Carson CC; Coward RM
    J Sex Med; 2015 Mar; 12(3):690-6. PubMed ID: 25580982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction.
    Arafa M; Eid H; El-Badry A; Ezz-Eldine K; Shamloul R
    Int J Impot Res; 2007; 19(2):213-7. PubMed ID: 16915304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peyronie's disease: a case study with clinical implications.
    Fisher DE; Lofton SP; Hale T; Durant N; Grant LF
    Urol Nurs; 2008 Apr; 28(2):109-12. PubMed ID: 18488585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peyronie's disease (CME).
    Bella AJ; Perelman MA; Brant WO; Lue TF
    J Sex Med; 2007 Nov; 4(6):1527-38. PubMed ID: 17970969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erectile function profiles in men with Peyronie's disease.
    Deveci S; Palese M; Parker M; Guhring P; Mulhall JP
    J Urol; 2006 May; 175(5):1807-11; discussion 1811. PubMed ID: 16600766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of erectile dysfunction in Peyronie's disease].
    Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
    Urologiia; 2001; (6):35-40. PubMed ID: 11785080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction.
    Yurkanin JP; Dean R; Wessells H
    J Urol; 2001 Nov; 166(5):1769-72; discussion 1772-3. PubMed ID: 11586221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.